Increased dissolution rates of carbamazepine – gluconolactone binary blends processed by hot melt extrusion

References

• Rubinstein A. Gastrointestinal anatomy, physiology and permeation pathways. In: Touitou E, Barry BW, eds. Enhancement in drug delivery. Boca Raton (FL): CRC Press; 2010:4–28
   Google Scholar
• Prajapati ST, Gohel MC, Patel LD. Studies to enhance dissolution properties of carbamazepine. Indian J Pharm Sci 2007;69:427--430
   Google Scholar
• Talukder R, Reed C, Durig T, Hussain M. Dissolution and solid-state characterization of poorly water-soluble drugs in the presence of a hydrophilic carrier. AAPS PharmSciTech 2011;12:1227–1233
   PubMed Web of Science ®Google Scholar
• Tian F, Sandler N, Aaltonen J, et al. Influence of polymorphic form, morphology, and excipient interactions on the dissolution of carbamazepine compacts. J Pharm Sci 2007;96:584–594
   PubMed Web of Science ®Google Scholar
• Saharan V, Kukkar V, Kataria M, et al. Dissolution enhancement of drugs. Part I: technologies and effect of carriers. Int J Health Res 2009;2:107–124
   Google Scholar
• Javadzadeh Y, Jafari-Navimipour B, Nokhodchi A. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). Int J Pharm 2007;341:26–34
   PubMed Web of Science ®Google Scholar
• Kou W, Cai C, Xu S, et al. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-beta-cyclodextrin in the presence of HPMC. Int J Pharm 2011;409:75–80
   PubMed Web of Science ®Google Scholar
• Moneghini M, Voinovich D, Perissutti B, Princivalle F. Action of carriers on carbamazepine dissolution. Pharm Dev Technol 2002;7:289–296
   PubMed Web of Science ®Google Scholar
• Rane Y, Mashru R, Sankalia M, Sankalia J. Effect of hydrophilic swellable polymers on dissolution enhancement of carbamazepine solid dispersions studied using response surface methodology. AAPS PharmSciTech 2007;8:E1–E11
   PubMed Web of Science ®Google Scholar
• Lefebvre C, Guyot-Herman AM. Polymorphic transitions of carbamazepine during grinding and compression. Drug Dev Ind Pharm 1986;12:1913–1927
   Web of Science ®Google Scholar
• Otsuka M, Hasegawa H, Matsuda Y. Effect of polymorphic transformation during the extrusion-granulation process on the pharmaceutical properties of carbamazepine granules. Chem Pharm Bull 1997;45:894–898
   Web of Science ®Google Scholar
• Davis TD, Peck GE, Stowell JG, et al. Modeling and monitoring of polymorphic transformations during the drying phase of wet granulation. Pharm Res 2004;21:860–866
   PubMed Web of Science ®Google Scholar
• Guo Z, Ma M, Wang T, et al. A Kinetic study of the polymorphic transformation of nimodipine and indomethacin during high shear granulation. AAPS PharmSciTech 2011;12:610–619
   PubMed Web of Science ®Google Scholar
• Allen LV, Popovich NG, Ansen HC. Pharmaceutical and formulation considerastions. Ansel's pharmaceutical dosage forms and drug delivery systems. 306. 9th ed. New York: Lippincott Williams & Wilkins; 2009:90–142
   Google Scholar
• Vippagunta SR, Brittain HG, Grant DJ. Crystalline solids. Adv Drug Deliv Rev 2001;48:3–26
   PubMed Web of Science ®Google Scholar
• Sun CQ, Grant DJW. Influence of crystal structure on the tableting properties of sulfamerazine polymorphs. Pharm Res 2001;18:274–280
   PubMed Web of Science ®Google Scholar
• Grzesiak AL, Lang MD, Kim K, Matzger AJ. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. J Pharm Sci 2003;92:2260–2271
   PubMed Web of Science ®Google Scholar
• Behme RJ, Brooke D. Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple-phase changes during differential scanning calorimetry analysis. J Pharm Sci 1991;80:986–990
   PubMed Web of Science ®Google Scholar
• Elqidra R, Unlu N, Capan Y, et al. Effect of polymorphism on in vitro in vivo properties of carbamazepine conventional tablets. J Drug Deliv Sci Tec 2004;14:147–153
   Web of Science ®Google Scholar
• Carino SR, Sperry DC, Hawley M. Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model. J Pharm Sci 2006;95:116–125
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Ito S, Itai S, Yamamoto K. Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate. Int J Pharm 2000;193:137–146
   PubMed Web of Science ®Google Scholar
• Otsuka M, Hasegawa H, Matsuda Y. Effect of polymorphic forms of bulk powders on pharmaceutical properties of carbamazepine granules. Chem Pharm Bull 1999;47:852–856
   Web of Science ®Google Scholar
• Nair R, Gonen S, Hoag SW. Influence of polyethylene glycol and povidone on the polymorphic transformation and solubility of carbamazepine. Int J Pharm 2002;240:11–22
   PubMed Web of Science ®Google Scholar
• Maniruzzaman M, Morgan DJ, Mendham AP, et al. Drug-polymer intermolecular interactions in hot-melt extruded solid dispersions. Int J Pharm 2013;443:199–208
   PubMed Web of Science ®Google Scholar
• Maniruzzaman M, Boateng JS, Snowden, MJ, Douroumis D. A review of hot-melt extrusion (HME): process technology to pharmaceutical products. ISRN Pharm 2012;2012:1–9
   Google Scholar
• Almeida A, Claeys B, Remon JP, Vervaet C. Hot-melt extrusion developments in the pharmaceutical industry. In: Douroumis D, ed. Hot-melt extrusion: pharmaceutical applications. West Sussex, United Kingdom: John Wiley & Sons, Ltd; 2012:43–69
   Google Scholar
• Wilson M, Williams MA, Jones DS, Andrews GP. Hot-melt extrusion technology and pharmaceutical application. Ther Deliv 2012;3:787–797
   PubMedGoogle Scholar
• Abu-Diak OA, Jones DS, Andrews GP. An investigation into the dissolution properties of celecoxib melt extrudates: understanding the role of polymer type and concentration in stabilizing supersaturated drug concentrations. Mol Pharm 2011;8:1362–1371
   PubMed Web of Science ®Google Scholar
• Thiry J, Krier F, Evrard B. A review of pharmaceutical extrusion: critical process parameters and scaling-up. Int J Pharm 2014, 479:227–240
   PubMed Web of Science ®Google Scholar
• Shah S, Maddineni S, Lu J, Repka MA. Melt extrusion with poorly soluble drugs. Int J Pharm 2013;453:233–252
   PubMed Web of Science ®Google Scholar
• UK. Food standard agency. Current EU approved additives and their E numbers [Internet]; 2013. Available from: http://www.food.gov.uk/science/additives/enumberlist [last accessed July 2014]
   Google Scholar
• Al-Hamidi H, Edwards AA, Mohammad MA, Nokhodchi A. UK-PharmSci 2010 – The Science of Medicines. Abstracts from the UK-PharmSci Conference, 1–3 September 2010. J Pharm Pharmacol 2010;62:1201–1516
   PubMedGoogle Scholar
• Tian F, Saville DJ, Gordon KC, et al. The influence of various excipients on the conversion kinetics of carbamazepine polymorphs in aqueous suspension. J Pharm Pharmacol 2007;59:193–201
   PubMed Web of Science ®Google Scholar
• Moradiya H, Islam MT, Woollam GR, et al. Continuous cocrystallization for dissolution rate optimization of a poorly water-soluble drug. Cryst Growth Des 2014;14:189–198
   Web of Science ®Google Scholar
• Al-Hamidi H, Edwards AA, Mohammad MA, Nokhodchi A. Glucosamine HCl as a new carrier for improved dissolution behaviour: effect of grinding. Colloid Surf B 2010;81:96–109
   PubMed Web of Science ®Google Scholar
• Al-Hamidi H, Edwards AA, Douroumis D, et al. Effect of glucosamine HCl on dissolution and solid state behaviours of piroxicam upon milling. Colloid Surf B 2013;103:189–199
   PubMed Web of Science ®Google Scholar